- In October 2024, Agilus Diagnostics announced the launch of its Pharmacogenomics Testing Service. This new offering provides healthcare professionals and patients with valuable insights into how an individual's genetic makeup affects drug response, supporting a more personalized and effective approach to treatment
- In October 2024, Genomind, a leader in personalized medicine and medication management through pharmacogenetics (PGx), announced the launch of its innovative Patient Report. This new report equips patients with clear, accessible insights into how their genetic profile affects their response to various medications
- In February 2023, MyRx—a new UF Health service developed by pharmacists at the University of Florida College of Pharmacy—was launched to offer patients a convenient way to interpret their pharmacogenetic test results and optimize drug therapy. This testing analyzes specific genes to help predict how individuals may respond to certain medications, guiding the selection of the most effective drugs and dosages while minimizing side effects
